Directory
>
Leslie Stolz
Leslie Stolz
Senior Vice President Regulatory Affairs | Verve Therapeutics
Cambridge, Massachusetts, United States
Leslie Stolz
Summary
Leslie Stolz is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as the Senior Vice President of Regulatory Affairs at Verve Therapeutics. With a robust academic background, including a Ph.D. in Molecular Cancer Biology from Duke University, Leslie has accumulated extensive experience in clinical development and regulatory strategy over a career spanning nearly three decades. Leslie's leadership roles at various organizations, including Syntimmune and Shire, highlight a strong track record in navigating complex regulatory landscapes. Their expertise encompasses a wide range of areas, from drug development to strategic planning, making them a valuable asset in the life sciences sector. Leslie is known for their ability to foster innovation while ensuring compliance with regulatory requirements, reflecting a unique blend of scientific acumen and strategic insight. Their commitment to advancing healthcare solutions is evident in their numerous contributions to clinical research and publications. Leslie's career trajectory showcases a consistent focus on improving patient outcomes through effective regulatory practices.
Leslie Stolz
Work Experience
Senior Vice President Regulatory Affairs at
Verve Therapeutics
June 2019 - Present
Vice President Regulatory Strategy at
Syntimmune
December 2016 - February 2019
Associate Director Regulatory Affairs at
Shire
February 2016 - November 2016
Director Regulatory Affairs at
Dyax
January 2014 - January 2016
Associate Director, Medical Communications at
Dyax
February 2008 - December 2013
Principal Medical Writer at
Boston Scientific
May 2004 - February 2008
Postdoctoral Fellow at
Pfizer
September 2001 - April 2004
Research Associate at
Thomas Jefferson University
July 1994 - June 1996
Leslie Stolz
Education
Duke University, Phd
January 1996 - January 2001
Villanova University, Bsc
January 1990 - January 1994
Frequently Asked Questions about Leslie Stolz
What is Leslie Stolz email address?
Leslie Stolz's primary email address is ******@vervetx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Leslie Stolz work for?
Leslie Stolz is a Senior Vice President Regulatory Affairs at Verve Therapeutics, a company specializing in Drugs, proprietaries, & sundries.
Where Leslie Stolz graduated from?
Leslie Stolz holds a degree in Molecular Cancer Biology from Duke University.
How can I directly contact Leslie Stolz?
To contact Leslie Stolz directly, you can use the email address ******@vervetx.com. Complete contact information is available upon registration with Muraena.
Who is Leslie Stolz?
Leslie Stolz is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as the Senior Vice President of Regulatory Affairs at Verve Therapeutics. With a robust academic background, including a Ph.D. in Molecular Cancer Biology from Duke University, Leslie has accumulated extensive experience in clinical development and regulatory strategy over a career spanning nearly three decades. Leslie's leadership roles at various organizations, including Syntimmune and Shire, highlight a strong track record in navigating complex regulatory landscapes. Their expertise encompasses a wide range of areas, from drug development to strategic planning, making them a valuable asset in the life sciences sector. Leslie is known for their ability to foster innovation while ensuring compliance with regulatory requirements, reflecting a unique blend of scientific acumen and strategic insight. Their commitment to advancing healthcare solutions is evident in their numerous contributions to clinical research and publications. Leslie's career trajectory showcases a consistent focus on improving patient outcomes through effective regulatory practices.
Leslie`s contact details
******@vervetx.com
******@dyax.com
Colleagues
Executive Director, External Manufacturing
Vice President, Translational Medicine
Vice President, Editing Development
Senior Vice President, Chemistry
Senior Vice President, Investor Relations and Corporate Communications